UK NEQAS Guildford Peptide Hormones
EPTIS Ringversuch Nr. 883868 | Letze Änderung 2021-09-16 | URL: https://www.eptis.bam.de/pts883868 https://www.eptis.bam.de/pts883868
| Name des Anbieters | |||||||||||||||||||||||||
| Name des Anbieters | UK NEQAS for Trace Elements and Peptide Hormones, Bershire and Surrey Pathology Services UK NEQAS for Trace Elements and Peptide Hormones, Bershire and Surrey Pathology Services | ||||||||||||||||||||||||
| Ansässig in | United Kingdom | ||||||||||||||||||||||||
| Sprache(n) | English | ||||||||||||||||||||||||
| Anmerkungen | The UK NEQAS Guildford Peptide Hormones Scheme has been running for over 40 years and assists participants in monitoring the hormones regulating glucose metabolism, growth and gastric function. Reports contain critical information about bias, reproducibility and, with occasional samples, recovery of added analyte. This is achieved with the use of International Reference Preparations (IRPs) and International Standards (IS), if they are not available, human recombinant materials. Selected distributions may also contain laboratory surveys or interpretative exercises to highlight current laboratory practice. | ||||||||||||||||||||||||
| Klassifizierung | |||||||||||||||||||||||||
| Produktgruppen |
Health care / medical devices
Human test material |
||||||||||||||||||||||||
| Prüfgebiete |
Analytical chemistry
Medical analysis |
||||||||||||||||||||||||
| Technische Einzelheiten | |||||||||||||||||||||||||
|
|||||||||||||||||||||||||
| Ringversuchsziele | |||||||||||||||||||||||||
| Zielgruppe des Ringversuchs | |||||||||||||||||||||||||
| Relevante Rechtsvorschriften oder Normen | |||||||||||||||||||||||||
| Weitere Ziele | |||||||||||||||||||||||||
| Teilnehmerzahl | |||||||||||||||||||||||||
| Anbieter unabhängig überprüft (akkreditiert, benannt, anerkannt) |
Akkreditiert durch United Kingdom Accreditation Service (UKAS) auf der Grundlage von ISO 17043:2010 |
||||||||||||||||||||||||
| Die Durchführung des Ringversuchs ist in Auftrag gegeben durch | |||||||||||||||||||||||||
| Kosten | |||||||||||||||||||||||||
| Teilnahmegebühr | Please contact provider on rsch.peptideeqa@nhs.net | ||||||||||||||||||||||||
| Regelmässig durchgeführt | Ja (Every 6 weeks (8 per annum)) | ||||||||||||||||||||||||
| Der Ringversuch wird durchgeführt seit | 1975 | ||||||||||||||||||||||||
| Kontaktdaten des Anbieters | |||||||||||||||||||||||||
| Anbieter | Kontaktperson | ||||||||||||||||||||||||
|
UK NEQAS for Trace Elements and Peptide Hormones, Bershire and Surrey Pathology Services
15 Frederick Sanger Road Guildford, GU2 7YD United Kingdom Telefon: +44 (01483)571122 ext 3611 Fax: Web: http://www.surreyeqas.org.uk/ http://www.surreyeqas.org.uk/ |
Mr Godwin Tetteh
Telefon: +44 (01483)571122 ext 3611 Fax: E-Mail: rsch.peptideeqa@nhs.net rsch.peptideeqa@nhs.net |
||||||||||||||||||||||||
Haben Sie einen Fehler entdeckt? Bitte wenden Sie sich an den zuständigen EPTIS Koordinator für United Kingdom,
Mr Savvas Xystouris.
Mr Savvas Xystouris.